Adapting the Rx-Risk-V for mortality prediction in outpatient populations

Medical Care

Volumn 44, Issue 8, 2006, Pages 793-797

  Johnson, Michael L ^a,b,d,e   El Serag, Hashem B ^a,b,c   Tran, Tung Thomas ^c   Hartman, Christine ^a,b   Richardson, Peter ^a,b   Abraham, Neena S ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Section of Health Services Research   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Case mix adjustment; Co morbidity in outpatients; Mortality prediction; Outcomes prediction; Rx Risk V

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; OUTPATIENT; RISK ASSESSMENT; VALIDATION STUDY; VETERAN;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; RISK ADJUSTMENT; RISK ASSESSMENT; VETERANS;

EID: 33747866940     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000218804.41758.ef     Document Type: Article

References (24)

1. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
2. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical co-morbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
3. Romano PS, Roos LL, Jollis JG. Adapting a clinical co-morbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-1079.
4. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000; 53:1258-1267.
5. Fetter RB. Casemix classification systems. Aust Health Rev. 1999;22: 16-34.
6. Ash AS, Ellis RP, Pope GC, et al. Using diagnoses to describe populations and predict costs. Health Care Finance Rev. 2000;21:7-28.
7. Weiner JP, Dobson A, Maxwell SL, et al. Risk-adjusted Medicare capitation rates using ambulatory and inpatient diagnoses. Health Care Financ Rev. 1996;17:77-99.
8. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med. 1997;127:666-674.
9. Black C, Roos NP. Administrative data. Baby or bathwater? Med Care. 1998;36:3-5.
10. Clark DO, Von Korff M, Saunders K, et al. A chronic disease score with empirically derived weights. Med Care. 1995;33:783-795.
11. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197-203.
12. Johnson RE, Hornbrook MC, Nichols GA. Replicating the chronic disease score (CDS) from automated pharmacy data. J Clin Epidemiol. 1994;47:1191-1199.
13. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol. 2000;29:891-898.
14. Schneeweiss S, Seeger JD, Maclure M, et al. Performance of Comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154:854-864.
15. Schneeweiss S, Wang PS, Avorn J, et al. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med. 2004;19:444-450.
16. Perkins AJ, Kroenke K, Unutzer J, et al. Common co-morbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol. 2004;57:1040-1048.
17. Sloan KL, Sales AE, Liu CF, et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003;41:761-774.
18. Fishman PA, Goodman MJ, Hornbrook MC, et al. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care. 2003;41:84-99.
19. Abraham NS, El Serag HB, Johnson ML, et al. National adherence to evidence based guidelines for the prescription of non-steroidal anti-inflammatory drugs. Gastroenterology. 2005;129:1171-1178.
20. Cowper DC, Kubal JD, Maynard C, et al. A primer and comparative review of major US mortality databases. Ann Epidemiol. 2002;12:462-468.
21. Schneeweiss S, Wang PS, Avorn J, et al. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003;38:1103-1120.
22. Ash A, Schwartz M. Evaluating the performance of risk-adjustment methods: dichotomous outcomes. In: Iezzoni L, ed. Risk Adjustment for Measuring Healthcare Outcomes. Chicago, IL: Health Administration Press; 1997.
23. Zhang JX, Iwashyna TJ, Christakis NA. The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims. Med Care. 1999;37:1128-1139.
24. Donabedian A. The definition of quality and approaches to its assessment. In: Explorations in Quality Assessment and Monitoring. Ann Arbor: Health Administration Press; 1980.